Literature DB >> 3488959

Human lymphocytes synthesize C-reactive protein.

T Ikuta, H Okubo, H Ishibashi, Y Okumura, K Hayashida.   

Abstract

We obtained evidence for the synthesis and secretion of C-reactive protein (CRP) by peripheral mononuclear cells in culture. Human mononuclear cells isolated from peripheral blood, after depletion of platelets, were cultured in glutamine-depleted RPMI 1640 supplemented with [3H]glutamine in the presence of 10-O-tetradecanoyl-phorbol-13-acetate (TPA). Anti-CRP antiserum was added to the culture medium, and the resultant immunoprecipitate was analyzed in SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The immunoprecipitate consisted of CRP, heavy and light chains of IgG, and only the CRP protein band had radioactivity, indicating that CRP was synthesized by mononuclear cells. In the populations of mononuclear cells, T-cell preparations mainly synthesized CRP, under stimulation of a factor derived from activated monocytes. Studies using the inhibitors of phospholipid metabolism suggested that generation of the monocyte factor was relevant to metabolites of an arachidonate cascade.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488959     DOI: 10.1007/BF00916118

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  MULTIPLICITY OF ANTIBODY PROTEINS IN RABBIT ANTI-P-AZOBENZENEARSONATE SERA.

Authors:  K ONOUE; Y YAGI; D PRESSMAN
Journal:  J Immunol       Date:  1964-02       Impact factor: 5.422

2.  Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis.

Authors:  J T Whicher; M F Martin; P A Dieppe
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

3.  Effects of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts.

Authors:  R A Mufson; D DeFeo; I B Weinstein
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

4.  Alpha 1-antitrypsin synthesis by human lymphocytes.

Authors:  T Ikuta; H Okubo; J Kudo; H Ishibashi; T Inoue
Journal:  Biochem Biophys Res Commun       Date:  1982-02-26       Impact factor: 3.575

5.  Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D.

Authors:  S B Mizel; D L Rosenstreich; J J Oppenheim
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

6.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Serum amyloid A: evidence for its origin in polymorphonuclear leukocytes.

Authors:  C J Rosenthal; L Sullivan
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Stimulation of prostaglandin synthesis by tumor-promoting phorbol-12, 13-diesters in canine kidney (MDCK) cells. Cycloheximide inhibits the stimulated prostaglandin synthesis, deacylation of lipids, and morphological changes.

Authors:  K Ohuchi; L Levine
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

9.  Tumor promoter stimulation of phosphatidylcholine turnover in HeLa cells.

Authors:  G R Guy; A W Murray
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

10.  Cultured human monocytes synthesize and secrete alpha2-macroglobulin.

Authors:  T Hovi; D Mosher; A Vaheri
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  3 in total

1.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

2.  Extrahepatic transcription of human C-reactive protein.

Authors:  T M Murphy; L L Baum; K D Beaman
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

Review 3.  New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.

Authors:  Fabrizio Montecucco; François Mach
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.